In this article

The Answers to Your Startup Equity Questions
Answers to questions about start up equity compensation, stock options, lay off considerations, stri...
Nearly 50 years ago, Silicon Valley introduced, among many other things, the practice of granting employees equity as part of their compensation package. Since then, the terms of earning your equity over time has remained largely unchanged. A common example of a vesting schedule is “four years, with a one year cliff,” which means that you earn your equity grant evenly over 4 years, except none of it is yours until you’ve passed your one-year employment mark.
With so much change over the years, it’s important to look at why the vesting schedule exists, what’s changed, and how it has been impacted.
According to the National Venture Capital Association, the median time to IPO was 3.1 years in 2000. Employees were granted equity that would vest until the company would go public, or even beyond that date – four years from when the employee started. Employees’ incentives and timeline were tied to that of the company. There were no (or perhaps very limited) issues of employees struggling to afford their exercise or pay AMT taxes. Publicly traded stocks make a cashless exercise a no-brainer and lower valuations while companies were still private kept exercise costs within reason. This vesting schedule seemed to work pretty well.
Today, venture backed companies are now waiting a median of eleven years after securing their first VC investment to IPO. Not only does the four-year vesting schedule not line up with the time to exit but other problems have been created in the process:
First, companies' and employees' incentives need to be aligned. Employees are awarded equity as compensation to encourage them to work hard and build that equity into something meaningful. A four-year horizon doesn’t quite line up with that anymore. Companies can offer new grants, but the employee who took a risk joining a smaller company 4 years ago is forced to pay a significantly higher price to own those new options. Or by the time they receive a new grant they may be considering other paths. Some thoughts to consider: Should the vesting schedule be lengthened? Should an employee vest relative to how early on they joined? Should they be able to lock in a lower exercise price at the beginning?
Furthermore, with private company valuations soaring as they stay private longer, many employees can’t afford the cost to exercise their options or pay their AMT Tax bill. This has forced many employees to leave their hard-earned options on the table if they move to another company. Things to consider: Should employees have the right to a cashless exercise? Should the expiration window be extended well beyond the current 90-day mark? Should options be worthless until they are sold and given value?
Companies are staying private much longer and are worth much more while private. As more people are leave high paying professions to help build small companies, new solutions are required to align employee and company incentives and empower employees to access their equity and its value. At EquityZen, we expect to see new alternatives as companies and employees navigate this changing landscape, and remain committed to supporting shareholders of growing private companies.
Answers to questions about start up equity compensation, stock options, lay off considerations, stri...
As companies are staying private longer the need for pre-IPO liquidity has become increasingly impor...
Big Tech isn't just buying startups—it's partnering with them. Learn how the Magnificent 7 (Amazon, ...
Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.
EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the U.S. Securities and Exchange Commission and is a FINRA/SIPC member firm.
Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.
EquityZen Inc. was awarded a 2024 Fintech Breakthrough Award by Tech Breakthrough LLC on March 19, 2025, based on the prior year and covering calendar year 2024, and has compensated FinTech Breakthrough LLC for use of its name and logo in connection with the award. FinTech Breakthrough LLC is a third party and has no affiliation with EquityZen.
EquityZen created the ticker symbols referenced on this page for use solely on the EquityZen platform. They do not refer to any publicly traded stock. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any of the companies featured and none of the statements on the site should be attributed to those companies.
“Market Activity” and other transactional data displayed on this website is compiled by EquityZen and is confidential and historical in nature. Unauthorized use, distribution or reproduction is prohibited. Transactional information does not guarantee future investment results. EquityZen cannot guarantee finding or approving a transaction at any displayed price.
EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2025 EquityZen. All rights reserved.
EquityZen Inc.
30 Broad Street,
Suite 1200
New York, NY 10004